The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 16, 2021

Filed:

Oct. 03, 2018
Applicant:

New Jersey Institute of Technology, Newark, NJ (US);

Inventors:

Rajesh N. Dave, Princeton, NJ (US);

Lu Zhang, Kearny, NJ (US);

Guluzar Gorkem Buyukgoz, Saddle Brook, NJ (US);

Eylul Cetindag, Piscataway, NJ (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/16 (2006.01); A61K 9/70 (2006.01); A61K 45/06 (2006.01); A61K 47/10 (2017.01); A61K 47/20 (2006.01); A61K 31/343 (2006.01); A61K 9/00 (2006.01); A61K 31/216 (2006.01); A61K 47/38 (2006.01); A61K 9/50 (2006.01);
U.S. Cl.
CPC ...
A61K 9/1682 (2013.01); A61K 9/006 (2013.01); A61K 9/7007 (2013.01); A61K 31/216 (2013.01); A61K 31/343 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01); A61K 47/20 (2013.01); A61K 9/501 (2013.01); A61K 47/38 (2013.01);
Abstract

The present disclosure provides improved film based pharmaceutical products containing uniformly distributed drug or active agent particles (e.g., to achieve improved/excellent dissolution control including enhancing dissolution and bioavailability and/or product uniformity). More particularly, the present disclosure provides improved systems/methods for fabricating film based pharmaceutical products by utilizing higher surface modified micronized drug or active agent powders and film forming precursors and drying methods that accomplish improved/efficient drying and provide improved/excellent content uniformity of active pharmaceutical agents in the fabricated film based pharmaceutical products. In exemplary embodiments, the present disclosure provides for an easier means of directly incorporating dry micronized poorly water-soluble drugs or active agent particles (e.g., fenofibrate ('FNB')) into films. The present disclosure demonstrates some advantages of direct incorporation of surface modified-micronized poorly water-soluble drug or active agent powders in film manufacturing.


Find Patent Forward Citations

Loading…